2012-2019年新乡市B型流感病毒基因的变异及流行趋势

马建敏; 程栋; 李华峰; 史晓娟; 栾旭波; 刘丹; 王梅

doi:10.16462/j.cnki.zhjbkz.2019.11.015

2012-2019年新乡市B型流感病毒基因的变异及流行趋势

doi: 10.16462/j.cnki.zhjbkz.2019.11.015

453002 新乡, 新乡市疾病预防控制中心卫生检测检验中心

基金项目:

2017年度河南省科技攻关计划项目 172102310093

详细信息

通讯作者:
马建敏, E-mail: majianmin690@126.com

中图分类号: R373.2;R331
计量
- 文章访问数: 392
- HTML全文浏览量: 219
- PDF下载量: 21
- 被引次数: 0
出版历程
- 收稿日期: 2019-04-25
- 修回日期: 2019-08-13
- 刊出日期: 2019-11-10

Genetic variations and epidemiological characteristics of influenza B virus in Xinxiang from 2012 to 2019

Section for Hygienic Monitoring and Testing, Xinxiang Center for Disease Control and Prevention, Xinxiang 453002, China

Funds:

Henan Science and Technology Research Project of 2017 172102310093

More Information

Corresponding author: MA Jian-min, E-mail: majianmin690@126.com

摘要

摘要: 目的研究新乡市B型流感病毒的流行状况和基因变异特征，为当地流感疫苗接种提供政策依据。方法对新乡市2012年1月-2019年2月流感监测结果进行分析，随机抽取分离的23株B型流感病毒，进行血凝素（hemagglutinin，HA）和神经氨酸酶（neuraminidase，NA）基因测序，使用DNAman软件进行序列比对，Neighbor-Joining法进行进化树分析。结果新乡市B型流感病毒Yamagata系（influenza B virus，Yamagata strain，BY）和Victoria系（influenza B virus，Victoria strain，BV）隔年交替流行，主要感染0~15岁人群（91.4%）；2015-2016年和2017-2018年的优势株与当年的三价疫苗成分不符。HA基因进化树显示，87.5%（7/8）的BV株与疫苗株同处一个分支；而88.98%（8/9）的2013-2015年BY株与同期疫苗株不在一个分支，其抗原表位的突变位点有N116K、S150L、N165Y、D196N和N202S。NA基因未发现耐药位点突变。有6个分离株发生了系间重配。结论 WHO推荐的三价疫苗株很多情况下与新乡B型流行株不符，推荐使用四价疫苗，并加强对15岁以下人群的接种；新乡BY流行株与疫苗株的HA基因差异较大，期待研发出适合我国本土的疫苗株。
- B型流感病毒 /
- 流行特征 /
- 基因特征 /
- 重配株
Abstract: Objective To investigate the genetic variation and epidemiological characteristics of influenza B virus in Xinxiang to provide policy basis for local influenza vaccination. Methods The influenza surveillance data in Xinxiang from January 2012 to February 2019 was analyzed. 23 isolated influenza B virus were randomly selected for hemagglutinin (HA) and neuraminidase (NA) gene sequencing. Sequence alignment was conducted by using DNAman software and phylogenetic tree analysis was conducted using Neighbor-Joining method. Results Yamagata (BY) and Victoria (BV) strains of influenza B virus circulated alternately every other year in Xinxiang, mainly among people aged 0-15 years (91.4%). The dominant influenza B lineages from 2015 to 2016 and from 2017 to 2018 did not match the corresponding trivalent vaccine strain of the year. The HA phylogenetic tree revealed that 87.5% (7/8) of BV strains coexisted with the vaccine strain in one branch, while 88.98% (8/9) of BY strains from 2013 to 2015 were not in the same branch as the corresponding vaccine strain, with 5 epitope site mutions N116K, S150L, N165Y, D196N and N202S. No drug-resistant site mutation was identified in the NA gene. A total of 6 intra-lineage reassortants were identified. Conclusions The influenza B lineage in the trivalent vaccine recommended by WHO did not match the dominant circulating B lineage of Xinxiang in some epidemic year. Therefore, quadrivalent vaccines are recommended to use in susceptible population, especially under the age of 15. In addition, there are large variations in HA gene of the epidemic BY strain compared with the corresponding vaccine. Then, a vaccine more sutable for the epidemic strains in China is expected to be developed.
- Influenza B virus /
- Epidemiological analysis /
- Genetic characteristics /
- Reassortant

HTML全文

图 1 新乡市2012-2019年B型流感流行状况

Figure 1. Influenza B virus epidemic characteristics in Xinxiang, 2012-2019

下载: 全尺寸图片幻灯片

图 2 2012-2019年新乡市2种B型流感病毒流行特点

Figure 2. The epidemic feature of 2 influenza B lineages in Xinxiang from 2012 to 2019

下载: 全尺寸图片幻灯片

图 3 2012-2019年新乡市B型流感病毒HA基因进化树

注: ●为疫苗株；▲为参考株

Figure 3. Phylogenetic tree of HA gene of influenza B virus detected in Xinxiang from 2012 to 2019

下载: 全尺寸图片幻灯片

图 4 2012-2019年新乡市B型流感病毒NA基因进化树

注: ●为疫苗株；▲为参考株；▼为BV-HA/BY-NA重配株；◆为BY-HA/BV-NA重配株；○代表病毒株基因型与血清型不符。

Figure 4. Phylogenetic tree of NA gene of influenza B virus detected in Xinxiang from 2012 to 2019

下载: 全尺寸图片幻灯片

参考文献(16)

[1]	Yang JR, Huang YP, Chang FY, et al. Phylogenetic and evolutionary history of influenza B viruses, which caused a large epidemic in 2011-2012, Taiwan[J]. PLoS One, 2012, 7(10): e47179. DOI: 10.1371/journal.pone.0047179.
[2]	Wang H, Fu CX, Li KB, et al. Influenza associated mortality in Southern China, 2010-2012[J]. Vaccine, 2014, 32(8): 973-978. DOI: 10.1016/j.vaccine.2013.12.013.
[3]	新乡市人民政府. 新乡市人民政府办公室关于印发《新乡市流感疫苗接种实施方案》的通知(政府公报2008年)[EB/OL]. (2008-10-22)[2019-3-1]. http://www.xinxiang.gov.cn/sitegroup/root/html/ff8080812470b81b012470d4626b001d/20091030172430204.html. Xinxiang Municipal People's Government. Notice on the Issuance of the "Implementation Plan for Influenza Vaccination in Xinxiang Municipality" issued by the office of Xinxiang Municipal People's Government. Government Gazette No. 10, 2008[EB/OL]. (2008-10-22)[2019-3-1]. http://www.xinxiang.gov.cn/sitegroup/root/html/ff8080812470b81b012470d4626b001d/20091030/172430204.html.
[4]	Du XJ, Dong LB, Yu L, et al. Mapping of H3N2 influenza antigenic evolution in China reveals a strategy for vaccine strain recommendation[J]. Nat Commun, 2012, 3: 709. DOI: 10.1038/ncomms1710.
[5]	Lo YC, Chuang JH, Kuo HW et al. Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season[J]. PLoS One, 2013, 8(3): e58222. DOI: 10.1371/journal.pone.0058222.
[6]	成艳辉, 王钊, 肖宁, 等. 2013-2014年中国B型流感病毒抗原性及基因特性分析[J]. 中华实验和临床病毒学杂志, 2015, 29(5): 385-390. DOI: 10.3760/cma.j.issn.1003-9279.2015.05.001. Cheng YH, Wang Z, Xiao N, et al. Antigenic and genetic characteristics of influenza B virus in the mainland of China 2013-2014[J]. Chin J Exp Clin Virol, 2015, 29(5): 385-390. DOI: 10.3760/cma.j.issn.1003-9279.2015.05.001
[7]	Wang Q, Cheng F, Lu M, et al. Crystal structure of unliganded influenza B virus hemagglutinin[J]. J Virol, 2008, 82(6): 3011-3020. DOI: 10.1128/JVI.02477-07.
[8]	李希妍, 成艳辉, 谭敏菊, 等. 2012-2013流感监测年度中国大陆B型流感病毒抗原性及基因特性分析[J]. 疾病监测, 2014, 29(1): 14-19. DOI: 10.3784/j.issn.1003-9961.2014.01.005. Li XY, Cheng YH, Tan MJ, et al. Antigenic and genetic characteristics of influenza B virus in the mainland of China, 2012-2013[J]. Disease Surveillance, 2014, 29(1): 14-19. DOI: 10.3784/j.issn.1003-9961.2014.01.005.
[9]	Lei N, Wang HB, Zhang YS, et al. Molecular evolution of influenza B virus during 2011-2017 in Chaoyang, Beijing, suggesting the free influenza vaccine policy[J]. Sci Rep, 2019, 9(1): 2432. DOI: 10.1038/s41598-018-38105-1.
[10]	Chen R, Holmes EC. The Evolutionary Dynamics of Human Influenza B Virus[J]. J Mol Evol, 2008, 66(6): 655-663. DOI: 10.1007/s00239-008-9119-z.
[11]	Oong XY, Ng KT, Lam TT-Y, et al. Epidemiological and Evolutionary Dynamics of Influenza B Viruses in Malaysia, 2012-2014[J]. PLoS One, 2015, 10(8): e0136254. DOI: 10.1371/journal.pone.0136254.
[12]	Shih AC, Hsiao TC, Ho MS, et al. Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution[J]. Proc Natl Acad Sci USA, 2007, 104(15): 6283-6288. DOI: 10.1073/pnas.0701396104.
[13]	方斌, 刘琳琳, 李翔, 等. 2010-2015年湖北省乙型流感病毒流行和进化分析[J]. 疾病监测, 2016, 31(7): 554-560. DOI: 10.3784/j.issn.1003-9961.2017.05.009. Fang B, Liu LL, Li X, et al. Epidemiological and evolutionary characteristics of influenza B viruses in Hubei, 2010-2015[J]. Disease Surveillance, 2016, 31(7): 554-560. DOI: 10.3784/j.issn.1003-9961.2017.05.009.
[14]	万永虎, 张德著, 郑勤妮, 等. 贵阳市2012-2015年B型流行性感冒病毒血凝素基因特性分析[J]. 中华疾病控制杂志, 2017, 21(3): 282-286. DOI: 10.16462/j.cnki.zhjbkz.2017.03.016. Wang YH, Zhang DZ, Zheng QN, et al. Genetic characteristic of haemagglutinin of influenza B virus in Guiyang, 2012-2015[J]. Chin J Dis Control Prev, 2017, 21(3): 282-286. DOI: 10.16462/j.cnki.zhjbkz.2017.03.016.
[15]	Langat P, Raghwani J, Dudas G, et al. Genome-wide evolutionary dynamics of influenza B viruses on a global scale[J]. PLoS Pathog, 2017, 13(12): e1006749. DOI: 10.1371/journal.ppat.1006749.
[16]	Belshe RB, Coelingh K, Ambrose CS, et al. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity[J]. Vaccine, 2010, 28(9): 2149-2156. DOI: 10.1016/j.vaccine.2009.11.068.